Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...

The College of American Pathologists recently updated its evidence-based guideline recommendations for the testing of human papillomavirus in head and neck carcinomas. Guideline co-chairs William ...

According to a 2021 study published by the Cancer Society, African Americans have a higher risk of developing oral cancer and a higher likelihood of dying from it compared to white Americans.

Q1 2025 Earnings Call Transcript May 12, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is ...

Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting Enrollment ongoing in FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC ...

Laryngeal squamous cell carcinoma (LSCC) is a prevalent malignancy with high mortality and recurrence rates, necessitating novel therapeutic strategies. Recent research highlights the pivotal role of ...

They analyzed 295 patients with newly diagnosed stage cT2-4N0-2M0 squamous cell carcinoma of the oropharynx, larynx, or hypopharynx who were randomly assigned in a 2:1 ratio to receive definitive ...

Such areas may resemble or be at higher risk for oral squamous cell carcinoma (SCC). Without routine biopsies ... the stromal cell therapy revealed an overall improvement in oropharyngeal mucositis on ...

Topline data were announced from a phase 3 trial evaluating tarlatamab-dlle (Imdelltra ®) for the treatment of small cell lung cancer (SCLC) in patients who progressed on or after a single line of ...

Stratification factors included primary tumor site (oropharynx/oral cavity vs larynx vs hypopharynx ... response (mPR), defined as 10% or less residual invasive squamous cell carcinoma in resected ...

Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma ...